ev3 neurovascular




  • EV3
    ... leader and best-in-class technology provider for specialists treating a wide range of vascular diseases and disorders. ev3 is committed to the peripheral vascular and neurovascular ...
    http://www.ev3.net/

  • ev3 Announces Neurovascular Division Management Change
    PLYMOUTH, Minn., April 3 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Matthew Jenusaitis has joined the company as President of its Neurovascular Division
    http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story....

  • EV3 » News & Events » News » Article
    ev3 Announces Neurovascular Division Management Change Apr 03, 2006. PLYMOUTH, Minn., April 3 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced that Matthew ...
    http://www.ev3.net/press/news/article/?&reqid=838122

  • EV3 - Employment
    This is an exciting time for ev3, Neurovascular - we're growing with new product development on the horizon and we're looking for the right individual to join our dynamic team!
    https://ev3.tms.hrdepartment.com/cgi-bin/a/highlightjob.cgi?jobid=275&....

  • President, Neurovascular Division, ev3 Inc.
    Smart Business, the management journal for corporate growth. Providing best practices and winning business strategies from the nation's most successful CEO and insight and advice ...
    http://www.sbnonline.com/Local/Article/13215/77/0/Matthew_Jenusaitis.a....

  • ev3 Inc. Reports Second Quarter 2008 Financial Results - Forbes.com
    In the second quarter of 2008, ev3's neurovascular segment net sales increased 24% to $30.7 million versus $24.8 million in the second quarter of 2007.
    http://www.forbes.com/prnewswire/feeds/prnewswire/2008/07/28/prnewswir....

  • ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global ...
    ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International PLYMOUTH, Minn., July 21 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq:
    http://www.reuters.com/article/pressRelease/idUS180302+21-Jul-2008+PRN....

  • ev3 Inc. Reports Third Quarter 2008 Financial Results: Financial News ...
    In the third quarter of 2008, ev3's neurovascular segment net sales increased 26% to $33.1 million versus $26.4 million in the third quarter of 2007.
    http://biz.yahoo.com/prnews/081031/aqf507.html?.v=24

  • ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global ...
    ev3 Inc. Announces Promotion of Pascal E.R. Girin to Lead Global Neurovascular Business and International. - PLYMOUTH, Minn., July 21 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq:
    http://au.us.biz.yahoo.com/prnews/080721/aqm515.html?.v=15

  • ev3 Inc. Reports First Quarter Financial Results
    Unfortunately, we also incurred non-cash charges related to the purchase of the minority interest in ev3 Neurovascular as well as higher than planned litigation and business ...
    http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story....



Keyword Tool